Carnegie Capital Asset Management, LLC Abbott Laboratories Transaction History
Carnegie Capital Asset Management, LLC
- $4.4 Billion
- Q1 2025
A detailed history of Carnegie Capital Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 301,562 shares of ABT stock, worth $38.6 Million. This represents 0.91% of its overall portfolio holdings.
Number of Shares
301,562
Previous 197,549
52.65%
Holding current value
$38.6 Million
Previous $22.3 Million
79.03%
% of portfolio
0.91%
Previous 0.66%
Shares
33 transactions
Others Institutions Holding ABT
# of Institutions
3,577Shares Held
1.38BCall Options Held
9.72MPut Options Held
8.83M-
Vanguard Group Inc Valley Forge, PA170MShares$21.7 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$9.94 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.55 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.49 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $224B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...